期刊文献+

阿仑膦酸钠对人成骨细胞株MG63活性功能的影响

Effects of Alendronate on the Function of Osteoblasts
原文传递
导出
摘要 本文研究了阿仑膦酸钠(Alen)对成骨细胞活性功能的影响,为其临床应用提供细胞学实验支持。采用体外细胞培养的方法观察不同浓度Alen对人成骨细胞株MG63细胞增殖、细胞形态、碱性磷酸酶(ALP)、Ⅰ型胶原以及钙沉积效应的影响。结果表明:较低浓度(1×10-9 mol/L和1×10-7 mol/L)时,Alen对MG63细胞增殖、细胞形态、ALP表达和Ⅰ型胶原合成无明显影响;在高浓度(1×10-5 mol/L)时,MG63细胞的增殖活性受到抑制,电镜观察可见细胞凋亡;浓度为1×10-9 mol/L时,Alen能促进MG63细胞的钙沉积,而浓度为10-5 mol/L时可抑制MG63细胞的钙沉积。本研究提示低浓度Alen能在一定程度上促进人成骨细胞的矿化能力,有利于骨形成。 To provide a support to the clinical application of alendronate (Alen) on cytology, we studied the effects of Alen on the function of osteoblasts. In this experiment, we observed the influence of MG63 cell line coincubation with Alen at concentrations of 1 × 10-9 mol/L, 1× 10-7 mol/L or 1× 10-5 mol/L on the osteoblastic function (pro liferation, cell morphology, alkali phosphatase (ALP) activity, expression of type I collagen and effect of calcium deposition). The proliferation, cell morphology, ALP activity and type I collagen synthesis of MG63 were not af fected by Alen at concentration of 1 ×10-9 mol/L and 1×10-7 mol/L, but the ALP activity as well as type I collagen production were promoted at higher concentration (1 ×10-5 tool/L). The calcium deposition of MG63 could be in creased at the lower concentration(1 × 109 tool/L), while it was inhibited at the higher concentration. In conclu sion, Alen at low concentration can promote the mineralization ability of osteoblasts to a certain extent, and this ben efits the bone formation.
出处 《生物医学工程学杂志》 EI CAS CSCD 北大核心 2012年第5期908-912,共5页 Journal of Biomedical Engineering
关键词 阿仑膦酸钠 人成骨细胞株MG63 Alendronate (Alen) Human osteoblastic MG63 cells line
  • 相关文献

参考文献8

  • 1KIM H K, KIM J H, ABBAS A A, et al. Alendronate en-hances osteogenic differentiation of bone marrow stromal cells:a preliminary study [J].Clin Orthop Relat Res,2009,467(12): 3121-3128.
  • 2IM G I,QURESHI S A, KENNEY J, et al. Osteoblast prolif-eration and maturation by bisphosphonates[J].Biomaterials,2004, 25(18): 4105-4115.
  • 3FOLLET H, LI J, PHIPPS R J, et al. Risedronate and alen-dronate suppress osteocyte apoptosis following cyclic fatigueloading[J].Bone, 2007, 40(4): 1172-1177.
  • 4DUQUE G, RIVAS D. Alendronate has an anabolic effect onbone through the differentiation of mesenchymal stem cells[J].J Bone Miner Res, 2007,22(10) : 1603-1611.
  • 5ROMANELLO M, BIVI N, PINES A, et al. Bisphosphonatesactivate nucleotide receptors signaling and induce the expres-sion o? Hsp90 in osteoblast-like cell lines[J].Bone, 2006, 39(4): 739-753.
  • 6金群华,田丰年,朱建华,陆志东,陈志荣.阿仑磷酸钠对成骨细胞增殖、分泌和成骨功能的影响[J].中华实验外科杂志,2004,21(1):71-72. 被引量:16
  • 7刘亦恒,张寿,张海英.阿仑磷酸钠对大鼠成骨细胞代谢调控的研究[J].中国现代医学杂志,2010,20(16):2442-2444. 被引量:6
  • 8周丽珍,向青,刘忠厚.合理使用骨质疏松症诊疗的骨代谢标志物指南(2004年版)[J].中国骨质疏松杂志,2004,10(4):397-404. 被引量:22

二级参考文献35

  • 1[1]NIH Consensus Development Panel on Osteoporosis Prevention. Diagnosis and Therapy. JAMA 2001,285:785-795.
  • 2[2]Weinstein RS. True strength. J Bone Miner Res 2000,15:621-625.
  • 3[3]Chesnut Ⅲ CH, Rosen CJ for the Bone Quality Discussion Group. Reconsidering the effects of antiresorptive therapies in reducing osteoporotic fracture. J Bone Miner Res 2001,16:2163-2172.
  • 4[4]Marcus R, Wong M, Heath Ⅲ H, et al. Antiresorptive treatment of posrmenopausal osteoporosis: comparison of study designs and outcomes in large clinical trials with fracture as an endpoint. Endocrine Rev 2002,23:16-37.
  • 5[5]Orimo H, Hayashi Y, Fukunaga M, et al. Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 2001,19:331-337.
  • 6[6]Cummings SR, Karpf DB, Harris F, et al. Improvement of spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 2002,112: 282-289.
  • 7[7]Heaney RP. Is the paradigm shifting? Bone 2003,33:457-465.
  • 8[8]Garnero P, Hausherr E, Chapuy MC, et al. Markers of bone resorption predict hip fracture in elderly women; EPIDOS prospective study. J Bone Mineral Res 1996,11:1531-1538.
  • 9[9]Garnero P, Sornay-Rendu E, Claustrar B, et al. Biochemical markers of bone turnover, endogenous hormones and the risk of fracture in postmenpausal women: the OFELY study. J Bone Miner Res 2000, 15: 1526-1536.
  • 10[10]Ross PD, Kress BC, Parson RE, et al. Serum bone alkaline phosphatase and calcaneus bone density predict fractures; a prospective study. Osteoporos Int 2000,11:76-82.

共引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部